Method for transferring nucleic acid into striated muscles

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

Reexamination Certificate

active

06939862

ABSTRACT:
The invention provides a method of transferring in vivo a molecule into a striated muscle cell. More specifically, a method of the invention comprises contacting in vivo a striated muscle cell with a molecule, and electrically stimulating the muscle cell with one or more unipolar pulses of an electric field intensity ranging from 1 to 800 V/cm2. In one embodiment, the molecule is a nucleic acid encoding a protein of interest. For example, the invention provides methods of promoting angiogenesis and hemostasis.

REFERENCES:
patent: 4411657 (1983-10-01), Galindo
patent: 4441972 (1984-04-01), Pohl
patent: 4474570 (1984-10-01), Ariura et al.
patent: 4476004 (1984-10-01), Pohl
patent: 4557723 (1985-12-01), Sibalis
patent: 4578168 (1986-03-01), Hofmann
patent: 4622031 (1986-11-01), Sibalis
patent: 4639244 (1987-01-01), Rizk et al.
patent: 4663292 (1987-05-01), Wong et al.
patent: 4695547 (1987-09-01), Hilliard et al.
patent: 4702732 (1987-10-01), Powers et al.
patent: 4764473 (1988-08-01), Matschke et al.
patent: 4776349 (1988-10-01), Nashef et al.
patent: 4786277 (1988-11-01), Powers et al.
patent: 5019034 (1991-05-01), Weaver et al.
patent: 5049488 (1991-09-01), Baer et al.
patent: 5081990 (1992-01-01), Deletis
patent: 5119832 (1992-06-01), Xavier
patent: 5124259 (1992-06-01), Tada
patent: 5128257 (1992-07-01), Baer
patent: 5273525 (1993-12-01), Hofmann
patent: 5282785 (1994-02-01), Shapland et al.
patent: 5286254 (1994-02-01), Shapland et al.
patent: 5304120 (1994-04-01), Crandell et al.
patent: 5304486 (1994-04-01), Chang
patent: 5318514 (1994-06-01), Hofmann
patent: 5371003 (1994-12-01), Murray et al.
patent: 5389069 (1995-02-01), Weaver
patent: 5425703 (1995-06-01), Feiring
patent: 5439440 (1995-08-01), Hofmann
patent: 5462520 (1995-10-01), Hofmann
patent: 5464386 (1995-11-01), Hofmann
patent: 5468223 (1995-11-01), Mir
patent: 5499971 (1996-03-01), Shapland et al.
patent: 5501662 (1996-03-01), Hofmann
patent: 5543282 (1996-08-01), Mihayashi et al.
patent: 5589069 (1996-12-01), Wenzhi
patent: 5607691 (1997-03-01), Hale et al.
patent: 5662944 (1997-09-01), Petrucco
patent: 5667491 (1997-09-01), Pliquett et al.
patent: 5674267 (1997-10-01), Mir et al.
patent: 5679647 (1997-10-01), Carson et al.
patent: 5685274 (1997-11-01), Helmbrecht et al.
patent: 5688233 (1997-11-01), Hofmann et al.
patent: 5693622 (1997-12-01), Wolff et al.
patent: 5702359 (1997-12-01), Hofmann et al.
patent: 5744133 (1998-04-01), Lathe et al.
patent: 5749847 (1998-05-01), Zewert et al.
patent: 5804566 (1998-09-01), Carson et al.
patent: 5810762 (1998-09-01), Hofmann
patent: 5814603 (1998-09-01), Oldenburg et al.
patent: 5849719 (1998-12-01), Carson et al.
patent: 5944710 (1999-08-01), Dev et al.
patent: 5944726 (1999-08-01), Blaeser et al.
patent: 5960974 (1999-10-01), Kee et al.
patent: 5993434 (1999-11-01), Dev et al.
patent: 6007806 (1999-12-01), Lathe et al.
patent: 6014584 (2000-01-01), Hofmann et al.
patent: 6055453 (2000-04-01), Hofmann et al.
patent: 6110161 (2000-08-01), Mathiesen et al.
patent: 6228844 (2001-05-01), Wolff et al.
patent: 6241701 (2001-06-01), Hofmann
patent: 6426216 (2002-07-01), Perricaudet et al.
patent: 6678556 (2004-01-01), Nolan et al.
patent: 6696420 (2004-02-01), Perricaudet et al.
patent: 2002/0099323 (2002-07-01), Dev et al.
patent: 0 140 308 (1985-05-01), None
patent: 0 185 573 (1986-06-01), None
patent: 0 259 212 (1988-03-01), None
patent: 0 321 201 (1989-06-01), None
patent: 2 681 786 (1993-04-01), None
patent: 2 688 514 (1993-09-01), None
patent: 2113 097 (1983-08-01), None
patent: 10-234366 (1998-08-01), None
patent: WO 89/06555 (1989-07-01), None
patent: WO 93/06223 (1993-04-01), None
patent: WO 93/19191 (1993-09-01), None
patent: WO 95/23211 (1995-08-01), None
patent: WO 96/00111 (1996-01-01), None
patent: WO 96/01414 (1996-01-01), None
patent: WO 96/39226 (1996-12-01), None
patent: WO 96/39531 (1996-12-01), None
patent: WO 97/07826 (1997-03-01), None
patent: WO 97/10343 (1997-03-01), None
patent: WO 98/43702 (1998-10-01), None
patent: WO 99/06101 (1999-02-01), None
patent: WO 99/36563 (1999-07-01), None
patent: WO 00/02621 (2000-01-01), None
Aihara et al., “Gene Transfer into Muscle by Electroporation In Vivo,”Nature Biotechnology,16, pp. 867-870 (1998).
Gorza et al., “Slow-to-Fast Transformation of Denervated Soleus Muscles by Chronic High-Frequency Stimulation in the Rat,”Journal of Physiology,402, pp. 627-649 (1988).
Heller et al., “In Vivo Gene Electroinjection and Expression in Rat Liver,”FEBS Letters,389, pp. 225-228 (1996).
Kim et al., “Electroporation of Extraneous Proteins into CHO Cells: Increased Efficacy by Utilizing Centrifugal Force and Microsecond Electrical Pulses,”Experimental Cell Research,197, pp. 207-212 (1991).
Lee et al., “Surfactant-induced Sealing of Electropermeabilized Skeletal Muscle Membranes in Vivo,”Proc. Natl. Acad. Sci. USA,89, pp. 4524-4528 (1992).
Mathiesen et al., “Regulation of the Size and Distribution of Agrin-Induced Postsynaptic-like Apparatus in Adult Skeletal Muscle by Electrical Muscle Activity,”Molecular and Cellular Neuroscience,13, pp. 207-217 (1999).
Mathiesen, I., “Electropermeabilization of Skeletal Muscle Enhances Gene Transfer In Vivio,”Gene Therapy,5, pp. 508-514 (1999).
Nishi et al., “High-Efficiency In Vivo Gene Transfer Using Intraarterial Plasmid DNA Injection Following In Vivo Electroporation,”Cancer Research,56, pp. 1050-1055 (1996).
Rizzuto et al., “Efficient and Regulated Erythropoietin Production by Naked DNA Injection and Muscle Electroporation,”Proc. Natl. Acad. Sci. USA,96, pp. 6417-6422 (1999).
Rols et al., “In Vivo Electrically Mediated Protein and Gene Transfer in Murine Melanoma,”Nature Biotechnology,16, pp. 168-170 (1998).
Rols et al., “Highly Efficient Transfection of Mammalian Cells by Electric Field Pulses,”Eur. J. Biochem.206, pp. 115-121 (1992).
Sixou et al., “Optimized Conditions for Electrotransformation of Bacteria are Related to the Extent of Electropermeabilization,”Biochimica et Biophysica Acta,1088, pp. 135-138 (1991).
Tatham et al., “ATP-induced Pore Formation in the Plasma Membrane of Rat Peritoneal Mast Cells,”J. Gen. Physiol.,95, pp. 459-476 (1990).
Teissie et al., “An Experimental Evaluation of the Critical Potential Difference Inducing Cell Membrane Electropermeabilization,”Biophysical Journal,65, pp. 409-413 (1993).
Titomirov et al., “In Vivo Electroporation and Stable Transformation of Skin Cells of Newborn Mice by Plasmid DNA,”Biochimica et Biophysica Acta,1088, pp. 131-134 (1991).
Tsurumi et al., “Direct Intramuscular Gene Transfer Of Naked DNA Encoding Vascular Endothelial Growth Factor Augments Collateral Development Tissue Perfusion”,Circulation,94(12), pp. 3281-3290 (1996).
J.-P. Behr et al. “Efficient Gene Transfer into Mammalian Primary Endocrine Cells with Lipopolyamine-coated DNA,”Proc. Natl. Acad. Sci. USA86:6982-6986 (1989).
O. Boussif et al. “A Versitile Vector for Gene and Oligonucleotide Transfer into Cells in Culture and in Vivo: Polyethylenimine,”Proc. Natl. Acad. Sci. USA92:7297-7301 (1995).
I. Danko et al. “Pharmacological Enhancement of in Vivo Foreign Gene Expression in Muscle,”Gene Therapy1:114-121 (1994).
H.L. Davis et al. “Direct Gene Transfer into Skeletal Muscle in Vivo: Factors Affecting Efficiency of Transfer and Stability of Expression,”Human Gene Therapy4:151-159 (1993).
H.L. Davis et al. “DNA Vaccine for Hepatitis B: Evidence for Immunogenicity in Chimpanzees and Comparison with Other Vaccines,”Proc. Natl. Acad. Sci. USA93:7213-7218 (1996).
P.L. Felgner et al. “Lipofection: A Highly Efficient, Lipid-Mediated DNA-transfection Procedure,”Proc. Natl. Acad. Sci. USA84:7413-7417 (1987).
J. Jouanneau et al. “Secretred or Nonsecreted Forms of Acidic Fibroblast Growth Factor Produced by Transfected Epithelial Cells Influence Cell Morphology Motili

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Method for transferring nucleic acid into striated muscles does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for transferring nucleic acid into striated muscles, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for transferring nucleic acid into striated muscles will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3372911

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.